| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |